CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Orion Biotech Opportunities Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Orion Biotech Opportunities Corp
One Vanderbilt Avenue, 26Th Floor
Phone: (212) 303-7822p:212 303-7822 NEW YORK, NY  10017  United States
This company ceased filing statements with the SEC on 5/11/2023.
On 4/24/2023, the Company announced it would not consummate a business combination and will cease all operations except for the purpose of winding up
This company is no longer actively traded on any major stock exchange.
Business Summary
Orion Biotech Opportunities Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company intends to focus on the biotechnology and life sciences industries. It has no operations and has generated no revenues.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202212/31/2022YesYes---

Industries
SIC Code Description
6726 Unit investment trusts, face-amount certificate offices
6770 Blank checks

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director James Z.Huang 56
Chief Financial Officer, Secretary MarkKayal 37
Vice President, General Counsel, Assistant Secretary, Director RobertSimonds 48
4 additional Officers and Directors records available in full report.

Business Names
Business Name
ORIA
ORIAU

General Information
Outstanding Shares: 25,000,000 (As of 12/31/2022)
Shareholders: 4
Stock Exchange: OTC


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024